Biotechnology Jobs

• Grimsby
• US$188,100 – US$313,500 pa
• Director

Leads quantitative systems pharmacology and QST modelling within a clinical pharmacology and quantitative medicine group, building mechanistic models of disease and drug action and running simulations to inform trial design. Defines and coordinates MIDD strategies across respiratory, immunology and inflammation programmes, working with biologists, clinicians, pharmacometricians and statisticians. Combines inverse-problem modelling, scientific ML and statistical methods to support decisions from exploratory research through clinical development.

• Stevenage
• £74,250 – £202,125 pa
• Lead

Joins the Genomic Technologies group within Translational Sciences, working in an existing Statistical Genetics team. Develops and tests production methods for analysing large-scale human genetic data, integrating genetic association data across omic and phenotypic layers to identify causal genes, drug targets and biomarkers. Collaborates with Data and Predictive Sciences, Biostatistics, AI/ML and disease area teams to influence portfolio decisions.

PySpark · BigQuery · Docker +3

• London
• Hybrid · 2–3 days in office
• Senior

Embedded forward deployed engineer role in GSK's Enterprise AI team, working within the Chemical Manufacturing & Control area to prototype AI solutions at days-to-weeks cadence. Focuses on document authoring and generation for regulatory filings, agentic workflows, RAG, knowledge systems and LLM evaluation, with heavy daily use of AI coding agents. Proven prototypes are handed off to a Sr. Solutions Engineer for scale-up.

Claude Code · GitHub Copilot · Databricks AI Assistant +3

• Stevenage
• Hybrid · 2–3 days in office
• Senior

Embedded with CMC business teams, you take high-priority AI use cases from problem framing to working prototypes at days-to-weeks cadence, then ship first production versions. The work centres on document authoring and generation for regulatory filings, building agentic and RAG pipelines, human-in-the-loop review workflows, and LLM evaluation with golden datasets and regression testing.

Claude Code · GitHub Copilot · Databricks AI Assistant +5

• London
• Hybrid · 2–3 days in office
• US$187,275 – US$312,125 pa
• Director

Leads the scientific design and execution of interventional clinical studies within Medical Affairs, providing medical governance, safety data review and scientific oversight of protocols and analysis plans. Collaborates with cross-functional teams, investigators and thought leaders, and presents results for publications and regulatory submissions. Hybrid role with two to three days per week in office.

Digital Tools

• Waltham, United States
• Hybrid · 2–3 days in office
• US$187,275 – US$312,125 pa
• Director

Leads the scientific design and execution of interventional clinical studies within Medical Affairs, providing medical governance, safety data review and scientific oversight of protocols and analysis plans. Collaborates with cross-functional teams, investigators and thought leaders, and presents results for publications and regulatory submissions. Hybrid role with two to three days per week in office.

• Waltham, United States
• Hybrid · 2 days in office
• US$284,250 – US$473,750 pa
• Director · manages people

Leads a team of early clinical development medical directors and clinical scientists, owning Phase I/II clinical development plans including first-in-human, dose-escalation and proof-of-concept studies in lung and head/neck cancers. Bridges preclinical discovery and clinical development, driving translational and biomarker strategy, regulatory submissions and cross-functional matrix teams.

AI/ML

• Stevenage
• Hybrid · 2 days in office
• US$284,250 – US$473,750 pa
• Director · manages people

Leads a team of medical directors and clinical scientists designing and executing early-phase oncology trials, including first-in-human, dose-escalation and proof-of-concept studies, while bridging preclinical discovery and clinical development. Accountable for clinical development plans, benefit-risk, regulatory submissions and translational biomarker strategy across lung and head/neck cancer assets.

AI/ML

• Zug, Switzerland
• Hybrid · 2 days in office
• US$284,250 – US$473,750 pa
• Director · manages people

Leads a team of early clinical development medical directors and clinical scientists, owning Phase I/II clinical development plans including first-in-human, dose-escalation and proof-of-concept studies in lung and head/neck cancers. Bridges preclinical discovery and clinical development, driving translational and biomarker strategy with cross-functional and regulatory partners.

AI/ML

• London
• Hybrid · 2 days in office
• US$284,250 – US$473,750 pa
• Director · manages people

Leads a team of medical directors and clinical scientists designing and executing early-phase oncology trials, including first-in-human and proof-of-concept studies, while bridging preclinical discovery and clinical development. Accountable for clinical development plans, translational and biomarker strategy, and regulatory submissions across a lung and head/neck cancer portfolio.

AI/ML

• Waltham, United States
• Hybrid
• US$204,000 – US$340,000 pa
• Director

Leads the design and execution of real-world evidence and health outcomes studies for oncology assets, managing timelines, budgets and quality of protocols, analyses and publications. Advises internal medical, market access and commercial teams and external experts on evidence strategy for HTA submissions, reimbursement and value-based pricing. Requires close collaboration across a matrix and deep knowledge of real-world data sources and payer needs.

• London
• Hybrid
• US$204,000 – US$340,000 pa
• Director

Leads the design and execution of real-world evidence and health outcomes studies across oncology assets, managing timelines, budgets and quality of protocols, analyses and publications. Advises internal medical, market access and commercial teams and external experts on evidence strategy for HTA submissions, reimbursement and value-based pricing, while building knowledge of real-world data sources and payer needs.

• Rockville Tower Oaks Blvd
• Hybrid
• US$204,000 – US$340,000 pa
• Director

Leads the design and delivery of real-world evidence and health outcomes studies across oncology assets, managing protocols, budgets, timelines and vendor deliverables. Partners with medical, market access, R&D and commercial teams plus external experts to shape evidence for HTA submissions, reimbursement and value-based pricing. Requires deep knowledge of RWD sources and payer evidence requirements.

• Durham Blackwell Street
• Hybrid
• US$204,000 – US$340,000 pa
• Director

Leads the design and delivery of real-world evidence and health outcomes studies for oncology assets, managing protocols, budgets, vendors and reporting from concept to publication. Advises medical, market access and commercial teams on payer and HTA evidence needs, and builds relationships with external experts and data partners.

• London
• On-site
• US$284,250 – US$473,750 pa
• Director

Leads clinical development of oncology assets in genitourinary cancers, overseeing Phase 1-3 interventional trials from protocol design through final study report. Provides real-time medical monitoring, safety review with pharmacovigilance, and regulatory document authoring, while building relationships with key external experts. Serves as a core member of the Clinical Matrix Team and contributes to disease area strategy and business development diligence.